Gilead Sciences (GILD) Shares Outstanding (Diluted) (2009 - 2026)
Gilead Sciences (GILD) recorded Shares Outstanding (Diluted) of 1.24 billion in Q2 2026, down 1.0% from 1.26 billion a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences reported Shares Outstanding (Diluted) of 1.26 billion, unchanged from FY2024.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 1.26 billion in FY2024 (-0.2%), 1.26 billion in FY2023 (-0.3%), 1.26 billion in FY2022 (unchanged) and 1.26 billion in FY2021 (-0.1%).
- The Q2 2026 figure is the lowest quarterly Shares Outstanding (Diluted) in data going back to Q1 2009.
- On a year-over-year basis, Shares Outstanding (Diluted) rose in two of the last eight quarters, with an average decline of 0.1%.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 1.0% in Q1 2025, against a decline of 1.1% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 1.25 billion (Q1 2026), 1.26 billion (Q4 2025) and 1.25 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 255.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Bn |
| Mar 31, 2026 | 1.25 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.25 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.26 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.26 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.26 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 1.26 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.26 Bn |
| Sep 30, 2021 | 1.26 Bn |
API Access
Gilead Sciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();